Gene expression analyses of Cluster 10. by Jillian A. Bristol (5566289)

A decrease in the row-2 and row-3 heights in low extracellular calcium is predicted by the model OHB to increase the resting receptor current and decrease the resting deflection of... by Rayan Chatterjee (21416840)

IC₅₀ of indole alkaloid against lipase [23]. by Atikarn Janthongkaw (17020498)

HR plots of % PCT decrease for survival (A) and recovery from dialysis (B) in predefined subgroups. by Il Young Kim (10757390)

S1 Dataset - by Nelmo Jordão Manjate (16324619)

“…For diagnosis by nasal Ag-RDTs, Panbio was MZN 547.00 (USD 8.90), COVIOS was MZN 768.00 (USD 12.50), and LumiraDx was MZN 798.00 (USD 13.00). Medical supplies expenditures represented the main driver of the final cost (>50%), followed by personnel and overhead costs (mean 15% for each). …”

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

Dynorphin Neuropeptides Decrease Apparent Proton Affinity of ASIC1a by Occluding the Acidic Pocket by Lilia Leisle (11356934)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

Preoperative and intraoperative variables split based on a ΔeGFR of 10%. by Rik H. J. Hendrix (7961477)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

“…<p><b>(A)</b><i>fapR</i> mRNA levels decrease in ACC and biotin related suppressor strains. …”

IgA is decreased in individual donor milk and is present in human milk-based fortifiers. by Christian Tamar (21100605)

Results obtained following a decrease in laser intensity by rotation of the Collison nebulizer. by Elliott Donghyun Kim (19469973)

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…<p>(A) HuH6 cells (2.5 x 10⁶ cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”

Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

“…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”

Protocol measures. by Sarah E. Maylott (14560785)

“…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”

Cry variables. by Sarah E. Maylott (14560785)

“…Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. We propose noninvasive clinical indicators of NOWS, including newborn neurobehavior, autonomic biomarkers, prenatal substance exposures, and socioeconomic environments. …”

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Phosphorylation can reduce toxicity and improve the stability of AMPs. Based on these, we designed a series of peptides and their corresponding phosphorylated forms. …”

DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Therefore, we designed a cyclic peptide PROTAC to achieve this efficient anti-PD-L1 effect.…”